PKO Investment Management Joint Stock Co purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,500 shares of the insurance provider's stock, valued at approximately $888,000.
A number of other hedge funds have also recently made changes to their positions in the company. Siemens Fonds Invest GmbH boosted its stake in shares of Humana by 23.7% during the fourth quarter. Siemens Fonds Invest GmbH now owns 7,567 shares of the insurance provider's stock valued at $1,920,000 after purchasing an additional 1,448 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Humana during the fourth quarter worth about $15,397,000. Forum Financial Management LP raised its position in shares of Humana by 62.0% during the fourth quarter. Forum Financial Management LP now owns 1,916 shares of the insurance provider's stock worth $486,000 after acquiring an additional 733 shares during the last quarter. Toronto Dominion Bank raised its position in shares of Humana by 7.4% during the fourth quarter. Toronto Dominion Bank now owns 64,447 shares of the insurance provider's stock worth $16,351,000 after acquiring an additional 4,455 shares during the last quarter. Finally, GF Fund Management CO. LTD. bought a new position in shares of Humana during the fourth quarter worth about $763,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on HUM shares. Wall Street Zen upgraded Humana from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Raymond James upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research report on Thursday, May 1st. Barclays raised their price objective on Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research report on Friday, April 11th. Royal Bank of Canada restated an "outperform" rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $290.00 price objective on shares of Humana in a research report on Thursday, May 1st. Sixteen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $286.81.
View Our Latest Research Report on HUM
Humana Stock Up 1.2%
Shares of NYSE HUM traded up $2.83 during midday trading on Friday, hitting $232.91. 2,524,287 shares of the stock traded hands, compared to its average volume of 1,780,835. The company has a market cap of $28.11 billion, a PE ratio of 23.41, a P/E/G ratio of 2.05 and a beta of 0.49. Humana Inc. has a one year low of $212.45 and a one year high of $406.46. The business has a 50 day moving average price of $257.11 and a two-hundred day moving average price of $266.80. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.
Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $7.23 earnings per share. On average, equities analysts predict that Humana Inc. will post 16.47 EPS for the current year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.52%. Humana's dividend payout ratio is 25.04%.
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.